share_log

中教控股:截至2023年8月31日止年度的末期股息

CHINA EDU GROUP: FINAL DIVIDEND FOR THE YEAR ENDED 31 AUGUST 2023

香港交易所 ·  Mar 1 03:54
Summary by Moomoo AI
中教控股(股份代號:00839)於2023年11月27日更新公告,宣布截至2023年8月31日止年度的末期股息為每股0.1353人民幣,並將於2024年3月27日派發。股東可選擇以現金或股份方式收取股息,若選擇股份,將按每股0.1481港幣的匯率換算。選擇權截止時限為2024年3月18日16:30,而除淨日則為2024年2月14日。股份過戶登記暫停日期為2024年2月16日至21日。董事會成員包括執行董事于果先生、謝可滔先生、喻愷博士及王睿先生,以及獨立非執行董事Gerard A. Postiglione博士、芮萌博士及鄔健冰博士。
中教控股(股份代號:00839)於2023年11月27日更新公告,宣布截至2023年8月31日止年度的末期股息為每股0.1353人民幣,並將於2024年3月27日派發。股東可選擇以現金或股份方式收取股息,若選擇股份,將按每股0.1481港幣的匯率換算。選擇權截止時限為2024年3月18日16:30,而除淨日則為2024年2月14日。股份過戶登記暫停日期為2024年2月16日至21日。董事會成員包括執行董事于果先生、謝可滔先生、喻愷博士及王睿先生,以及獨立非執行董事Gerard A. Postiglione博士、芮萌博士及鄔健冰博士。
CYNICS HOLDINGS (STOCK CODE: 00839) UPDATED ITS ANNOUNCEMENT ON 27 NOVEMBER 2023 TO DECLARE A FINAL DIVIDEND OF RMB 0.1353 PER SHARE FOR THE YEAR ENDED 31 AUGUST 2023 AND WILL BE DISTRIBUTED ON 27 MARCH 2024. Shareholders may elect to receive dividends in cash or shares. If they choose shares, they will be converted at an exchange rate of HK$0.1481 per share. The deadline for options is 16:30 on March 18, 2024 and the net date is February 14, 2024. The suspension date for share transfer registration is 16 to 21 February 2024. The members of the Board of Directors include Executive Directors Mr. Yu Gu, Mr. Xie Kei, Dr. Yu Kai and Mr. Wang Rui, as well as Independent Non-Executive Directors Dr. Gerard A. Postiglione, Dr. Lui Meng and Dr. Wu Jianbing.
CYNICS HOLDINGS (STOCK CODE: 00839) UPDATED ITS ANNOUNCEMENT ON 27 NOVEMBER 2023 TO DECLARE A FINAL DIVIDEND OF RMB 0.1353 PER SHARE FOR THE YEAR ENDED 31 AUGUST 2023 AND WILL BE DISTRIBUTED ON 27 MARCH 2024. Shareholders may elect to receive dividends in cash or shares. If they choose shares, they will be converted at an exchange rate of HK$0.1481 per share. The deadline for options is 16:30 on March 18, 2024 and the net date is February 14, 2024. The suspension date for share transfer registration is 16 to 21 February 2024. The members of the Board of Directors include Executive Directors Mr. Yu Gu, Mr. Xie Kei, Dr. Yu Kai and Mr. Wang Rui, as well as Independent Non-Executive Directors Dr. Gerard A. Postiglione, Dr. Lui Meng and Dr. Wu Jianbing.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more